Adherium

5 companies breathing life into the connected inhaler space (and their pharma partners)
By Jonah Comstock | 12:20 pm | November 03, 2015
Over the last two years, big pharma has gotten behind the idea of smartphone-connected inhalers for asthma and COPD in a big way.
Smart inhaler boosts medication adherence 144 percent in small study
By Jonah Comstock | 11:30 am | September 30, 2015
Adherium, the Australian connected inhaler company that partnered with AstraZeneca earlier this summer, has released data from three small studies of the company's Smartinhaler system.
AstraZeneca invests $3M in NZ smart inhaler maker Adherium
By Jonah Comstock | 07:54 am | August 19, 2015
Adherium Limited, a New Zealand company working on a smart inhaler, has raised $25.
AstraZeneca, Adherium to create smart inhaler adherence program for patients
By Aditi Pai | 06:26 am | July 27, 2015
AstraZeneca has partnered with New Zealand-based Adherium Limited, which offers a mobile-enabled inhaler, to incorporate digital health offerings into AstraZeneca’s patient support programs for people with COPD and asthma.